CompletedNot Applicable

Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorder

China144 participantsStarted 2019-09-01

Plain-language summary

Repetitive transcranial magnetic stimulation (rTMS) was used to treat methamphetamine use disorder in previous studies, while the evidence-based protocols still required. The aim of this research is to develop more applicable rTMS intervention pattern and protocols to reduce craving and relapse of methamphetamine-dependent patients.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders * Primary school degree or above * Normal vision and hearing * Dextromanual * Less than one month before last drug use Exclusion Criteria: * Have a disease that affect cognitive function such as history of head injury, cerebrovascular disease, epilepsy, etc * Have cognitive-promoting drugs in the last 6 months * Other substance abuse or dependence in recent five years (except nicotine) * Mental impairment, Intelligence Quotient (IQ) \< 70 * Mental disorders * Physical disease

What they're measuring

Change of Craving assessed by Visual Analog Scale

Timeframe: 12 months.

Trial details

NCT IDNCT03736317

SponsorShanghai Mental Health Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-02-01

View on ClinicalTrials.gov More Amphetamine Use Disorders trials